Skip to main content
Premium Trial:

Request an Annual Quote

John McCarthy, Bill Ward

ZS Genetics announced today that current board member John McCarthy has joined the company as Chief Executive Officer. McCarthy joins the firm after serving as CEO and Director of CryoXtract Instruments. McCarthy also previously served as president and CEO of Qteros and held various executive positions at companies that included Microbia, Verenium, Synta Pharmaceuticals, and Exact Sciences, as well as in the Investment Banking Group of Morgan Stanley. He also currently serves as chairman of the board of InVivo Therapeutics.

The firm also said that Bill Ward is retiring as president of ZS Genetics but will remain on the firm's scientific advisory board.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.